Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Satwinder Kaur Singh
Allogeneic Dendritic Cell (DC) Vaccination as an “Off the Shelf” Treatment to Prevent or Delay Relapse in Elderly Acute Myeloid Leukemia Patients: Results of Phase I/IIa Safety and Feasibility Study
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
Extramedullary Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Isolated Extramedullary Relapse in a Case of Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation
Research in Oncology
Phase I Study of Azacitidine Following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation
Leukemia Research
Cancer Research
Oncology
Hematology
A Phase I Study of Carfilzomib for Relapsed or Refractory Acute Myeloid and Acute Lymphoblastic Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Isolated Intracranial Myeloid Sarcoma Occurring as Relapse in Acute Myeloid Leukemia
Journal of Neurosciences in Rural Practice
Neuroscience
Neurology
Prophylaxis and Treatment of Acute Lymphoblastic Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation
OncoTargets and Therapy
Oncology
Pharmacology
Allogeneic Stem Cell Transplantation Following Relapse Post Autologous Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia: A Retrospective Analysis of 537 Patients From the Acute Leukemia Working Party of the EBMT
American Journal of Hematology
Hematology
Inferior Outcome of Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in First Complete Remission as Compared to De Novo Acute Myeloid Leukemia
Blood Cancer Journal
Oncology
Hematology
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse
JAMA Oncology
Cancer Research
Oncology